Common Contracts
5 similar Shareholder Support Agreement contracts by Anchiano Therapeutics Ltd., SciSparc Ltd.
SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • April 11th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This Shareholder Support Agreement, dated as of April 10, 2024 (this “Agreement”), is entered into by and among SciSparc Ltd., an Israeli limited company (the “Parent”) and each of the shareholders of AutoMax Motors Ltd. (the “Company”) listed on Schedule I hereto (the “Shareholders”).
FORM OF SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • January 13th, 2021 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
This Shareholder Support Agreement, dated as of December 14, 2020 (this “Agreement”), is entered into by and among Chemomab Ltd., an Israeli limited company (the “Company”) each of the shareholders of Anchiano Therapeutics Ltd. (“Parent”) listed on Schedule I hereto (the “Shareholders”) and solely for purposes of Section 4.7, Parent.
FORM OF SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • January 13th, 2021 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
This Shareholder Support Agreement, dated as of December 14, 2020 (this “Agreement”), is entered into by and among Anchiano Therapeutics Ltd., an Israeli limited company (the “Parent”) each of the shareholders of Chemomab Ltd. (“Company”) listed on Schedule I hereto (the “Shareholders”) and solely for purposes of Section 4.7, Company.
FORM OF SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • December 15th, 2020 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
This Shareholder Support Agreement, dated as of December 14, 2020 (this “Agreement”), is entered into by and among Anchiano Therapeutics Ltd., an Israeli limited company (the “Parent”) each of the shareholders of Chemomab Ltd. (“Company”) listed on Schedule I hereto (the “Shareholders”) and solely for purposes of Section 4.7, Company.
FORM OF SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • December 15th, 2020 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
This Shareholder Support Agreement, dated as of December 14, 2020 (this “Agreement”), is entered into by and among Chemomab Ltd., an Israeli limited company (the “Company”) each of the shareholders of Anchiano Therapeutics Ltd. (“Parent”) listed on Schedule I hereto (the “Shareholders”) and solely for purposes of Section 4.7, Parent.
